Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Aspirin Resistance at a Molecular Level in Aspirin-Treated Patients With Coronary Artery Disease

NCT00753935 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00753935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00753935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Aspirin Resistance at a Molecular Level in Aspirin-Treated Patients With Coronary Artery Disease
Lead sponsor
Vanderbilt University
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2006
Completion date
March 31, 2014
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease